Thymulin is a zinc-bound thymic nonapeptide studied across immune, anti-inflammatory, and lung models.

The short version

Thymulin is a small hormone made by the thymus, the immune-training gland tucked behind your breastbone. It is a nonapeptide (a chain of nine amino-acid building blocks), and here is its signature trick: it only switches on when one zinc atom is attached. Strip the zinc away and the molecule goes inert; add it back and activity returns ^[1]. In animal and lab studies, the zinc-bound form has shown effects on T cells (the immune system's trained defender cells), on inflammation, and across several lung models. Thymulin is a research peptide — not a supplement, not a drug, and not FDA-approved for anything.

What the thymulin literature actually shows

Thymulin (serum thymic factor; FTS / FTS-Zn) is a zinc-dependent thymic nonapeptide hormone, sequence pyroGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn, made exclusively by thymic epithelial cells (the gland's lining cells that build it) ^[2]. Its defining fact is mechanical and absolute: the peptide is biologically active only when bound to zinc in a 1:1 molar ratio, and the zinc-free apopeptide does nothing ^[1]. That single zinc ion is the whole power-up.

The research record reads like a stack of action panels. In a 1982 assay, chelating zinc out of the molecule with Chelex abolished its activity, and adding zinc back restored it — the result that earned the active form its name, thymulin ^[1]. In humans with mild zinc deficiency, circulating thymulin activity dropped even with normal plasma zinc and bounced back with zinc repletion ^[3]. In mice, thymulin lowered pro-inflammatory signals and dialed down the NF-kB pathway, a master switch that turns inflammation genes on ^[6]. And in one of the loudest findings in the whole literature, a single inhaled dose of thymulin-gene nanoparticles — given after asthma was already established — normalized key lung pathology in mice at 20 days ^[7].

None of that is a human treatment. Every result below is described as what was measured, in which species, with the citation right there. That is the entire job of this site: surface the findings, lead with the number, and keep the honest caveats loud. The thymulin research findings page lays out the mechanism and the key studies; why thymulin needs zinc goes deep on the activation switch.

Thymulin peptide: a zinc-dependent thymic nonapeptide

The thymulin peptide is nine amino acids long with the sequence pyroGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn (molecular formula C33H54N12O15, molecular weight roughly 858.9 Da, CAS 63958-90-7) ^[2]. It is endogenous — your body already makes it. Thymic epithelial cells secrete it from birth; levels peak in childhood and decline with age and with falling zinc status ^[2][3].

When a single zinc ion binds, the peptide folds into a specific active conformation that NMR studies can detect ^[2]. That zinc-bound shape is what classical assays score as biological activity, and what drives the T-cell differentiation thymulin is best known for ^[2]. Handled in the lab, thymulin is a research peptide — distinct from thymosin alpha-1, thymosin beta-4, and thymopentin, which are separate compounds with their own data. Conflating them is the single most common error in consumer write-ups, and this digest does not make it ^[4].

What the research describes: thymulin peptide effects studied in models

Across animal and in-vitro models, thymulin peptide benefits reported in the literature cluster into a few clean beats — and every one is a model finding, never a human claim. On the immune side, thymulin drives T-lymphocyte differentiation and, in chickens, enhanced lung natural-killer-cell cytotoxicity against a virus in a dose-dependent way ^[13]. On the anti-inflammatory side, in LPS-treated mice it lowered plasma pro-inflammatory cytokines and inducible heat-shock proteins while modulating NF-kB and SAPK/JNK signaling ^[6].

The dealt lens for this digest is the lung. In mice, a single intratracheal dose of thymulin-expressing plasmids reversed established experimental-asthma pathology at 20 days ^[7], and in rats, thymulin attenuated monocrotaline-induced pulmonary hypertension by modulating interleukin-6 and suppressing the p38 pathway ^[8]. The full thymulin lung research page breaks those down panel by panel.

Thymulin also acts on the neuroendocrine system as a hypophysiotropic peptide (one that signals the pituitary gland), part of a bidirectional thymus-neuroendocrine axis ^[4]. Big picture: large effect beats in models, a thin human record, and a mechanism that is unusually well defined for a peptide this size. For the amounts researchers actually administered, see thymulin dosage in studies.

What is thymulin?

Thymulin (serum thymic factor; FTS / FTS-Zn) is a zinc-dependent thymic nonapeptide hormone produced exclusively by thymic epithelial cells and biologically active only when bound to zinc in a 1:1 ratio ^[1][2]. It is studied as a research peptide and is not FDA-approved for any use. It is endogenous, declines with age and zinc deficiency, and is chemically distinct from other thymic peptides ^[4]. For the synonyms, the zinc switch, and the data, start with why thymulin needs zinc and the thymulin research findings.

The honest status, up front

CAREFUL — read this before anything else. Thymulin is not FDA-approved for any human indication and is handled as a research peptide for laboratory use only. It is not a dietary supplement. The strong findings here are preclinical — cell and animal models — plus a small, dated set of human observations, and several historical human studies used a synthetic analog (nonathymulin), not native thymulin. Because activity is strictly zinc-dependent, thymulin-specific effects are entangled with zinc status, which complicates interpretation. Nothing on this site is dosing guidance, medical advice, or an endorsement. See the frequently asked questions about thymulin for the plain-English version.